This website is owned and operated by the Journal of Fatima Jinnah Medical University (JFJMU). The Journal is committed to maintaining confidence and trust with respect to the information it collects from its viewers/users. The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
The Journal follows the Attribution Creative Commons-Non commercial (CC BY-NC) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC BY-NC license restricts the use of material for commercial purposes. For further details about the license please check the Creative Commons website. The editorial board of the journal strives hard for the authenticity and accuracy of the material published in the journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board.
The Journal of Fatima Jinnah Medical University requires a similarity index of 19% or less for acceptance of a submitted manuscript and uses the turnitin® software for detecting similarity indices. A similarity index of 19%-30% is required to be reviewed by the author and a similarity index of 40% or more is deemed sufficient to reject the submitted manuscript. JFJMU observes/follows the ICMJE, PMC, and HEC guidelines/criteria for all types of plagiarism. The same can be accessed at www.icmje.org, www.pmc.gov.pk, and www.hec.gov.pk
It is the authors’ responsibility to apprise themselves of plagiarism in any form including paraphrasing and self-plagiarism. Manuscripts submitted to JFJMU can be sent to HEC, other medical journals’ editors, and international agencies for authentication of originality. The disciplinary committee of JFJMU would deal with cases of plagiarism and comprise of the staff, editors, and the Chief Editor or his representative. For a plagiarized article in processing, the identification of actions will lead to dropping of an article from further processing/ consideration of publication. The author will be required to give an explanation on demand. In case of an unsatisfactory reply, the matter will be referred to the disciplinary committee that may decide the course of action. For published articles, the allegedly plagiarized article will be temporarily retracted from publication. The author will be served an explanation demand. In case of non-response in the stipulated time or unsatisfactory explanation, the article will be permanently retracted and the author will be on the watch. HEC, PMC, and the author’s institute will also be notified. In case of multiple submissions, other editors will also be informed. The author(s) will have to provide documentary proof of retraction from publication if such a defense is pleaded. Those claiming intellectual/idea or data theft of an article must provide documentary proof in their claim.
All publication misconducts are dealt with by first asking the corresponding author an explanation in view of the available evidence. In case of non -response or unsatisfactory response from the authors, the manuscript is dropped from consideration if unpublished and retracted if published. Due notice of retraction will be given in print and on the website. The authors will be blacklisted for further submissions and considerations at the journal. The authors' institutional Head will also be informed of the action in such a case. The other Editorial Associations may also be informed. Plagiarism and other publication misconduct, fabrication (picture as well), falsification, salami slice, a duplicate submission, redundant publication, multiple submission, selective and misleading reporting, selective and misleading referencing are liable to strict action.
Ethical Review of Human Subjects Research
The authors are required to declare if their experiments involving human subjects were conducted in accordance with the best ethical standards in place as described in the Helsinki Declaration and Independent Data and Safety Monitoring Committee ( IDMC) which is available at https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ and https://dcri.org/our-work/trial-support-services/independent-data-monitoring-committee/. It is pertinent to note that the use of any information that can lead to the identification of human subjects is strictly prohibited. Likewise, reports of experiments should state the institutional or national standards that were followed during experiments.
Manuscripts submitted to the JFJMU should be accompanied by approval from the ethics committee / ethical review board of the institution where the study was carried out. In conditions where no ethical approval was required for the study, a statement explaining the situation countersigned by the head of the department should be submitted to the JFJMU.
The Journal follows a double-blind peer review process in which neither the authors nor the reviewers know each other’s details. The submitted manuscripts will be reviewed for originality, scientific significance, and adequacy of documentation. Further, reviewers are also required to disclose any competing interests (e.g. affiliation with the drug company tested in the study, etc.) on the journal website regarding the manuscripts they are going to review. In case of any serious conflict of interest, another subject expert will be invited to review the manuscript. Authors are required to submit a complete list of byline authors, their affiliations, and contact details in a separate file along with the manuscript file. All the manuscripts submitted will be initially scrutinized within a week for completeness and formatting by the editorial staff. The manuscripts not prepared according to the instructions will be returned to the authors for any corrections/modifications before sending them for peer review. While manuscripts prepared according to the prescribed guidelines will be sent for peer review to at least two independent subject experts (i.e. subject experts affiliated to a different institute than the authors’ institute). The manuscripts will be accepted or rejected or sent for modifications according to the reviewers’ recommendations. In case of a difference of opinion among both subject experts, the manuscript will be sent to a third reviewer. All parts of accepted manuscripts are subject to editing for scientific accuracy and clarity by the office of the Editor. The manuscripts will undergo copyediting (including modifications in the text, table, and figures, etc.) and layout formatting by the editorial staff. Final articles will be sent to the corresponding authors for proofreading and acceptance of changes made by the editorial staff. The names of the reviewers will be strictly kept confidential and will not be disclosed at any point. Reviewers are expected to keep the scientific data strictly confidential and shall not keep its record or share it will any other colleague. Reviewers must also not use/quote data from the manuscript under review before its publication.